About
Contact & Profiles
A5060558989
Research Areas
- Gastrointestinal motility and disorders
- Trauma and Emergency Care Studies
- Peptidase Inhibition and Analysis
- Signaling Pathways in Disease
- Tryptophan and brain disorders
- Inflammasome and immune disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Sepsis Diagnosis and Treatment
- Heme Oxygenase-1 and Carbon Monoxide
- Gut microbiota and health
- interferon and immune responses
- Atherosclerosis and Cardiovascular Diseases
- Macrophage Migration Inhibitory Factor
- Disaster Response and Management
- Immune cells in cancer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
2023-2024
First Hospital of Shijiazhuang
2023
10.1016/j.clim.2023.109881
article
EN
Clinical Immunology
2023-12-23
To evaluate the predictive value of early warning scores for intensive care unit (ICU) admission in patients with coronavirus disease 2019 (COVID-19). For COVID-19 who were admitted to Shijiazhuang People's Hospital from January 2021 February 2021, national score (NEWS), 2 (NEWS2), rapid emergency medicine (REMS), quick sepsis-related organ failure (qSOFA), altered consciousness, blood urea nitrogen, respiratory rate, pressure, and age-65 (CURB-65) used inpatient condition ICU admission. A...
10.3760/cma.j.cn112138-20220414-00277
article
EN
PubMed
2023-04-01
Coming Soon ...